Pacemaking by HCN Channels Requires Interaction with Phosphoinositides
Overview
Authors
Affiliations
Hyperpolarization-activated, cyclic-nucleotide-gated (HCN) channels mediate the depolarizing cation current (termed I(h) or I(f)) that initiates spontaneous rhythmic activity in heart and brain. This function critically depends on the reliable opening of HCN channels in the subthreshold voltage-range. Here we show that activation of HCN channels at physiologically relevant voltages requires interaction with phosphoinositides such as phosphatidylinositol-4,5-bisphosphate (PIP(2)). PIP(2) acts as a ligand that allosterically opens HCN channels by shifting voltage-dependent channel activation approximately 20 mV toward depolarized potentials. Allosteric gating by PIP(2) occurs in all HCN subtypes and is independent of the action of cyclic nucleotides. In CNS neurons and cardiomyocytes, enzymatic degradation of phospholipids results in reduced channel activation and slowing of the spontaneous firing rate. These results demonstrate that gating by phospholipids is essential for the pacemaking activity of HCN channels in cardiac and neuronal rhythmogenesis.
Glucocorticoids Selectively Inhibit Hippocampal CA1 Pyramidal Neurons Activity Through HCN Channels.
Li C, Lu T, Pan C, Hu C Int J Mol Sci. 2024; 25(22).
PMID: 39596039 PMC: 11593447. DOI: 10.3390/ijms252211971.
Distinct Modulation of by Synaptic Potentiation in Excitatory and Inhibitory Neurons.
Herstel L, Wierenga C eNeuro. 2024; 11(11).
PMID: 39406481 PMC: 11574699. DOI: 10.1523/ENEURO.0185-24.2024.
PIP2 inhibits pore opening of the cyclic nucleotide-gated channel SthK.
Thon O, Wang Z, Schmidpeter P, Nimigean C Nat Commun. 2024; 15(1):8230.
PMID: 39300080 PMC: 11413322. DOI: 10.1038/s41467-024-52469-1.
Dopaminergic amacrine cells express HCN channels in the developing and adult mouse retina.
Romano E, Zhang D bioRxiv. 2024; .
PMID: 39091772 PMC: 11291019. DOI: 10.1101/2024.07.20.604440.
Control of sodium appetite by hindbrain aldosterone-sensitive neurons.
Kuralay A, McDonough M, Resch J Mol Cell Endocrinol. 2024; 592:112323.
PMID: 38936597 PMC: 11381173. DOI: 10.1016/j.mce.2024.112323.